Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pre-caesarean povidone-iodine vaginal cleansing for prevention of post-caesarean surgical site infection
PACTR202405865325160Not yet recruiting
- Sponsor
- self
- Start
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of povidone-iodine in surgical site infection (SSI) (2 arms), sponsored by self. Primary endpoints: Surgical site infection and Endometritis. Planned start May 2024; status: not yet recruiting.
02
Drugs
povidone-iodine
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on PACTR202405865325160.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202405865325160.